CervoMed Statistics
Share Statistics
CervoMed has 8.7M
shares outstanding. The number of shares has increased by 5.44%
in one year.
| Shares Outstanding | 8.7M |
| Shares Change (YoY) | 5.44% |
| Shares Change (QoQ) | 5.44% |
| Owned by Institutions (%) | 15.73% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,721 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 971.78K, so 11.17% of the outstanding
shares have been sold short.
| Short Interest | 971.78K |
| Short % of Shares Out | 11.17% |
| Short % of Float | 16.76% |
| Short Ratio (days to cover) | 1.06 |
Valuation Ratios
The PE ratio is -1.16 and the forward
PE ratio is -4.34.
CervoMed's PEG ratio is
-0.01.
| PE Ratio | -1.16 |
| Forward PE | -4.34 |
| PS Ratio | 1.94 |
| Forward PS | 5.2 |
| PB Ratio | 0.48 |
| P/FCF Ratio | -1.14 |
| PEG Ratio | -0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for CervoMed.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.11,
with a Debt / Equity ratio of 0.
| Current Ratio | 11.11 |
| Quick Ratio | 11.11 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $649,198.27 |
| Profits Per Employee | $-1,086,046.33 |
| Employee Count | 15 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -56.09% in the
last 52 weeks. The beta is -0.25, so CervoMed's
price volatility has been lower than the market average.
| Beta | -0.25 |
| 52-Week Price Change | -56.09% |
| 50-Day Moving Average | 7.37 |
| 200-Day Moving Average | 9.47 |
| Relative Strength Index (RSI) | 59.27 |
| Average Volume (20 Days) | 4,789,378 |
Income Statement
In the last 12 months, CervoMed had revenue of 9.74M
and earned -16.29M
in profits. Earnings per share was -2.02.
| Revenue | 9.74M |
| Gross Profit | 9.74M |
| Operating Income | -18.23M |
| Net Income | -16.29M |
| EBITDA | -18.23M |
| EBIT | -16.29M |
| Earnings Per Share (EPS) | -2.02 |
Full Income StatementBalance Sheet
The company has 9M in cash and 0 in
debt, giving a net cash position of 9M.
| Cash & Cash Equivalents | 9M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -70.73M |
| Total Assets | 43.08M |
| Working Capital | 39.2M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -16.53M
and capital expenditures 0, giving a free cash flow of -16.53M.
| Operating Cash Flow | -16.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -16.53M |
| FCF Per Share | -2.05 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -187.18% and -167.29%.
| Gross Margin | 100% |
| Operating Margin | -187.18% |
| Pretax Margin | -167.29% |
| Profit Margin | -167.29% |
| EBITDA Margin | -187.18% |
| EBIT Margin | -187.18% |
| FCF Margin | -169.76% |
